National Aids Commission (NAC) and health campaigners have welcomed the approval of a twice-a-year HIV prevention injection ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...

A study led by Harvard Medical School, explored the reason that causes the rise of aortic aneurysms, thus offering vital ...

The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...

India denies fake claims of US using its airspace for Iran strikes. PIB Fact Check confirms no Indian airspace was used in ...